New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent

2026-10-24来源 WiredEnglish
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

原文：https://www.a8q9.cn/en/article/new-mrna-vaccine-reduces-risk-of-melanoma-recurrence-by-over-40-percent-882254.html

相关文章